A cross-national factor analytic comparison of three models of PANSS symptoms in schizophrenia

Psychiatry Research

Volumn 219, Issue 2, 2014, Pages 283-289

  Stefanovics, Elina A ^a,b   Elkis, Helio ^c   Zhening, Liu ^d   Zhang, Xiang Y ^e   Rosenheck, Robert A ^a,b  

^a VA New England Mental Illness and Clinical Center (MIRECC)   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

^d CENTRAL SOUTH UNIVERSITY   (China)

^e BEIJING HUILONGGUAN HOSPITAL   (China)

Author keywords

Confirmatory factor analysis; Cross country comparison; Positive and Negative Scale

Indexed keywords

ADULT; ARTICLE; BRAZIL; CHINA; COMPARATIVE STUDY; CONFIRMATORY FACTOR ANALYSIS; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MATHEMATICAL MODEL; NATIONAL HEALTH ORGANIZATION; POSITIVE AND NEGATIVE SYNDROME SCALE; PRIORITY JOURNAL; SCHIZOPHRENIA; SCORING SYSTEM; SYMPTOMATOLOGY; TRADITIONAL TRIFACTORIAL MODEL; ADOLESCENT; AGED; CULTURAL FACTOR; FACTORIAL ANALYSIS; MIDDLE AGED; SYMPTOM ASSESSMENT; THEORETICAL MODEL; UNITED STATES; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; BRAZIL; CHINA; CROSS-CULTURAL COMPARISON; FACTOR ANALYSIS, STATISTICAL; FEMALE; HUMANS; MALE; MIDDLE AGED; MODELS, THEORETICAL; SCHIZOPHRENIA; SYMPTOM ASSESSMENT; UNITED STATES; YOUNG ADULT;

EID: 84904462605     PISSN: 01651781     EISSN: 18727123     Source Type: Journal    
DOI: 10.1016/j.psychres.2014.04.041     Document Type: Article

References (60)

1. Aggarwal N.K., Zhang X.Y., Stefanovics E.A., Chen D.C., Xiu M.H., Xu K., Rosenheck R.A. Rater evaluations for psychiatric instruments and cultural differences: the PANSS in China and United States. Journal of Nervous and Mental Disease 2012, 200(9):814-820.
2. Aggarwal N.K., Haojuan T., Xu K., Stefanovics E., Zhening L., Rosenheck R.A. Comparing the PANSS in Chinese and American inpatients: cross-cultural psychiatric analyses of instrument translation and implementation. Schizophrenia Research 2011, 132(2-3):146-152.
3. Akaike H. Factor analysis and AIC. Psychometrica 1987, 52:317-332.
4. Angrist B., Rotrosen J., Gershon S. Differential effects of amphetamine and neuroleptics on negative vs. positive symptoms in schizophrenia. Psychopharmacology 1980, 72:17-19.
5. Bae S.W., Brekke J.S. Characteristics of Korean-Americans with schizophrenia: a cross-ethnic comparison with Africa Americans, Latinos, and Euro-Americans. Schizophrenia Bulliten 2002, 28:703-717.
6. Bauer S.M., Schanda H., Karakula H., Olajossy-Hikesberger L., Rudaleviciene P., Okribelashvili N., Chaudhry H.R., Idemudia S.E., Gscheider S., Ritter K., Stompe T. Culture and the prevalence of hallucinations in schizophrenia. Comprehensive Psychiatry 2011, 52(3):319-325.
7. Bell Morris D., Lysaker Paul H., Milstein Robert M., Joseph L.Beam-Goulet Concurrent validity of the cognitive component of schizophrenia: Relationship of PANSS scores to neuropsychological assessments. Psychiatry Research 1994, 54(1):51-58.
8. Bhugra D., Corridan B., Rudge S., Leff J., Mallett R. Early manifestations, personality traits and pathways into care for Asian and white first-onset case of schizophrenia. Social Psychiatry and Psychiatric Epidemiology 1999, 34:595-599.
9. Bentler P.M., Dijkstra T. Efficient estimation via linearization in structural models. Multivariate analysis VI 1985.
10. Brekke J.S., DeBonis J.A., Graham J.W. A latent structure analysis of the positive and negative symptoms in schizophrenia. Comprehensive Psychiatry 1994, 35(4):252-259.
11. Chou C.P., Bentler P.M. Estimates and tests in structural modeling. Structural Equation Modeling: Concept, Issues, and Applications 1995, 37-55. Sage Publications Inc., Thousand Oaks. R.H. Hoyle (Ed.).
12. Crow T.J. Molecular pathology of schizophrenia: more than one disease process?. British Medical Journal 1980, 280:66-68.
13. de Leon J., Wilson W.H., Simpson G.M. Measurement of negative symptoms in schizophrenia. Psychiatric Developments 1989, 7:211-234.
14. Dzial J., Coffman D., Lanza S., Li R. Sensitivity and specificity of information criteria 2012, Penn State University, (Technical Report Series).
15. Dollfus S., Petit M. Principal-component analysis of PANSSS and SAND-SAPS in schizophrenia: their stability in an acute phase. European Psychiatry 1995, 10:97-106.
16. Emsley R., Rabinowitz J., Torreman M., The RIS-INT-35 Early Psychosis Global Working Group The factor structure for the Positive and Negative Syndrome Scale (PANSS) in recent-onset psychosis. Schizophrenia Research 2003, 61:47-57.
17. First M., Spitzer R., Gibbon M., Williams J. Structured Clinical Interview for DSM-IV Axis I Disorders - Administration Booklet 1994 1994, American Psychiatric Press, Inc., Washington DC.
18. Fredrikson D., Steiger J., MacEwan G., Altman S., Kopala L., Flyn S., Liddle P., Honer W. PANSS symptom factors in schizophrenia. Schizophrenia Research 1997, 24:15-16. (Special Issue: Abstracts of the VI International Congress on Schizophrenia Research).
19. Hayashi N., Igarashi Y., Yamashina M., Suda K. Is there as gender difference in a factorial structure of the positive and negative syndrome scale? A test by structural equation modeling. Psychopathology 2002, 35(1):28-35.
20. Higashima M., Urata K., Kawasaki Y., Maeda Y. P300 and the thought disorder factor extracted by factor-analytic procedures in schizophrenia. Biological Psychiatry 1998, 44(2):115-120.
21. Hu L., Bentler P.M. Fit Indices in covariance structure modeling: sensitivity to underparameterized model misspecification. Psychological Bulletin 1998, 3(4):424-453.
22. Igarashi Y., Hayashi N., Yamashina M., Otsuka N., Kuroki N., Anzai N., Kazamatsuri H. Interrater reliability of the Japanese version of the Positive and Negative Syndrome Scale and the appasialof its training effect. Psychiatry Clinical Neurosciences 1998, 52(5):467-470.
23. James L.R., Mulaik S.A., Brett J.M. Causal Analysis 1982, Sage, Beverly Hills.
24. Jiang J., Sim K., Lee J. Validated five-factor model of Positive and Negative Syndrome Scale for schizophrenia in Chinese population. Schizophrenia Research 2013, 143:38-43.
25. Kay S.R., Fiszbein A., Opler L.A. The Positive and Negative Syndrome Scale (PANSS) for Schizophrenia. Schizophrenia Bulletin 1987, 13(2):261-276.
26. Kay S.R., Sevy S. Pyramidical model of schizophrenia. Schizophrenia Bulletin 1990, 16(3):537-545.
27. Kawasaki Y., Maeda Y., Sakai N., Higashima M., Urata K., Yamaguchi N., Kurachi M. Evaluation and interpretation of symptom structures in patients with schizophrenia. Acta Psychiatrica Scandinavica 1994, 89(6):399-404.
28. Kim Jong-Hoon, Kim Seong-Youn, Lee Jinyoung, Oh Kyung-Jin, Kim Young-Bo, Cho Zang-Hee Evaluation of the factor structure of symptoms in patients with schizophrenia. Psychiatry Research 2012, 197:285-289.
29. Kline Rex Principles and Practice of Structurla Equation Modeling 2011, Guilford press, NY London.
30. Krawiecka M., Goldberg D., Vaughn M. A standardized psychiatric assessment scale for rating chronic psychotic patients. Acta Psychiatrica Scandinavica 1977, 55:299-308.
31. Lancon C., Auquie P., Nayt G., Reine G. Stability of the five-factor structure of the Positive and Negative Syndrome Scale (PANSS). Schizophrenia Research 2000, 42(3):231-239.
32. Lehoux C., Goeil M.-H., Lefebvre A.-A., Maziade M., Roy M.-A. The Five-Factor Structure of the PANSS: a critical Review of its consistency across studies. Clinical Schizophrenia and Related psychoses 2009, 2009:103-110.
33. Levine S., Rabinowitz J. Revisiting the 5 dimensions of the positive and negative syndrome scale. Journal of Clinical Psychopharmacology 2007, 27(5):413-436.
34. Lewine R.R.J., Fogg L., Meltzer H.Y. Assessment of negative and positive symptoms in schizophrenia. Schizophrenia Bulletin 1983, 9:368-376.
35. Lei M., Lomax R.G. The effect of varying degrees of non-normality in structural equation modeling. Structural Equation Modeling 2005, 12(1):1-27.
36. Lieberman J.A., Stroup S., McEvoy J.P., Swartz M.S., Rosenheck R.A., Perkins D.O., Keefe R.S.E., Davis S.M., Davis E.C., Lebowitz B.D., Severe J., Hsiao J.K., for the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Investigators Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. New England Journal of Medicine 2005, 353(12):1209-1223.
37. Lindenmayer J.P., Grochowki S., Hyman R.B. Five factor model of schizophrenia: replication across samples. Schizophrenia Research 1995, 14(3):229-234.
38. Lykouras L., Oulis P., Psarros K., Daskalopoulou E., Botsis A., Christodoulou G.N., Stefanis C. Five-factor model of schizophrenic psychopathology: how valid is it?. European Archives of Psychiatry and Clinical Neuroscience 2000, 250(2):93-100.
39. Lee K.-H., Harris A.W., Loughland C.M., Williams L.M The five symptom dimensions and depression in schizophrenia. Psychopathology 2003, 36(5):226-233.
40. Lim C.S., Subramaniam M., Poon L.Y., Chong S.A., Varma S. Cross-ethnic differences in severity of symptomatology of individuals with first-episode schizophrenia spectrum disorder. Early Intervention in Psychiatry 2011, 5(3):242-248.
41. Mass R., Schoemig T., Hitschfeld K., Wall E., Haasen C. Psychopathological syndromes of schizophrenia: evaluation of the dimensional structure of the positive and negative syndrome scale. Schizophrenia Bulletin 2000, 26(1):167-177.
42. Overall J.E., Gorham D.R. The Brief Psychiatric Rating Scale (BPRS): recent developments in ascertainment and scaling. Psychopharmacological Bulletin 1988, 24:97-99.
43. Peuskens, J., 1992. PANSS in international multicenter trials. Presented at the First International Risperidone Investigator Meeting, Paris, France.
44. Powell Douglas A., Schafer William D. The robustness of the likelihood ratio chi-square test for structural equation models: A meta-analysis. Journal of Educational and Behavioral Statistics 2001, 26(1):105-132.
45. Rodriguez-Jimenez R., Bagney A., Mezquita L., Martinez-Gras I., Sanchez-Morla E.-M., Mesa N., Ibanez M.-I., Diez-Martin J., Jimenez-Arriero M.-A., Lobo A., Santos J.-L., Palomo T., PARG Cognition and the five-factor model of the Positive and Negative Syndrome Scale in schizophrenia. Schizophrenia Research 2013, 143:77-83.
46. Rosenheck R.A., Leslie D., Keefe R., McEvoy J., Swartz M., Perkins D., Stroup S., Hsiao J., Lieberman J. Barriers to employment for people with schizophrenia. American Journal of Psychiatry 2006, 163(3):411-417.
47. Russo M., Levine S., Di Forti M., Stefania Bonaccorso S., Fearon P., Dazzan P., Pariante C., David A., Morgan R., Reichenberg A. Association between symptom dimensions and categorical diagnoses of psychosis: a cross-sectional and longitudinal investigation. Schizophrenia Bulletin 2014, 40(1):111-119.
48. Singh M.M., Kay S.R. Anticholinergic-neuroleptic antagonism in terms of positive and negative symptoms of schizophrenia: implications for psychobiological subtyping. Psychological Medicine 1987, 17:39-48.
49. Schaefer J.L., Graham J.W. Missing data: our view of the state of the art. Psychological Methods 2002, 7:147-177.
50. Schwarz G. Estimating the dimension of a model. The Annals of Statistics 1978, 6(2):461-464.
51. Strauss J.S., Carpenter W.T., Bartko J.J. The diagnosis and understanding of schizophrenia: Part III. Speculations on the processes that underlie schizophrenic symptoms and signs. Schizophrenia Bulletin 1974, 11:61-69.
52. Stroup T.S., McEvoy J.P., Swartz M.S., Byerly M.J., Glick I.D., Canive J.M., McGee M.F., Simpson G.M., Stevens M.C., Lieberman J.A. The National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) project: schizophrenia trial design and protocol development. Schizophrenia Bulletin 2003, 29:15-31.
53. van den Oord E.J.C.G., Rujescu D., Robles J.R., Giegling I., Birrell C., Bukszár J., Murrelle L., Moller H.-J., Middleton L., Muglia P. Factor structure and external validity of the PANSS revisited. Schizophrenia Research 2006, 82:213-223.
54. van der Gaag M., Cuijpers A., Hoffman T., Remijsen M., Hijman R., de Haan L., van Meijel B, van Harten P.N., Valmaggia L., de Hert M., Wiersma D. The five-factor model of the Positive and Negative Syndrome Scale II: A ten-fold cross-validation of revised model. Schizophrenia Research 2006, 85:280-287.
55. van der Gaag M., Cuijpers A., Hoffman T., Remijsen M., Hijman R., de Haan L., van Meijel B., van Harten P.N., Valmaggia L., de Hert M., Wiersma D. The five-factor model of the positive and negative Syndrome Scale I: confirmatory factor analysis fails to confirm 25 published five-factor solutions. Schizophrenia Research 2006, 85:273-279.
56. von Knorring Lars, Lindström E. The Swedish version of the Positive and Negative Syndrome Scale (PANSS) for schizophrenia: Construct validity and interrater reliability. Acta Psychiatrica Scandinavica 1992, 86(6):463-468.
57. Versola-Russo J. Cultural and demographic factors of schizophrenia. International Journal Psychosocial Rehabilitation 2006, 10(2):89-103.
58. Wallwork R.S., Fortgang R., Hashimoto R., Weinbereger D.R., Dichinson D. Searching for a consensus five-factor model of the positive and Negative Syndrome Scale for schizophrenia. Schizophrenia Research 2012, 137(1-3):246-250.
59. White L., Harvey P.D., Opler L., Lindenmayer J.P. Empirical assessment of the factorial structure of clinical symptoms in schizophrenia. Psychopathology 1997, 30:263-274.
60. Wolthaus J.E.D., Dingemans P.M.A.J., Schene A.H., Linszen D.H., Knegtering H., Holthausen E.A.E., Cahn W., Hijman R. Component structure of the Positive and Negative Syndrome Scale (PANSS) in patients with recent-onset schizophrenia and spectrum disorders. Psychopharmacology 2000, 150:399-403.